DA Davidson has just upgraded shares of Martek Biosciences (Nasdaq: MATK) from Underperform to Neutral following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE